Company page

Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. is a public company traded under the ticker ORMP in the American market. With a market capitalization of approximately $158.8 million, Oramed focuses on developing innovative oral drug delivery systems, particularly for diabetes treatment. The company aims to improve patient outcomes through its proprietary technologies.